Patent · US Active

Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent

US9820977B2 · kind B2 · utility

0Cited by
1References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 22, 2009
Grant dateNov 21, 2017
Priority date
Expiry dateMay 22, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P33/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pharmaceutically acceptable single parasiticidal agent compositions of imidacloprid for oral delivery to mammals to systemically control targeted blood-sucking or blood-consuming parasites, such as fleas, ticks and certain species of helminthes and scabies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.